BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22820174)

  • 1. The novel ETA receptor antagonist HJP-272 prevents cerebral microvascular hemorrhage in cerebral malaria and synergistically improves survival in combination with an artemisinin derivative.
    Dai M; Freeman B; Bruno FP; Shikani HJ; Tanowitz HB; Weiss LM; Reznik SE; Stephani RA; Desruisseaux MS
    Life Sci; 2012 Oct; 91(13-14):687-92. PubMed ID: 22820174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal glyceryl trinitrate as an effective adjunctive treatment with artemether for late-stage experimental cerebral malaria.
    Orjuela-Sánchez P; Ong PK; Zanini GM; Melchior B; Martins YC; Meays D; Frangos JA; Carvalho LJ
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5462-71. PubMed ID: 23979751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artemether and artesunate show the highest efficacies in rescuing mice with late-stage cerebral malaria and rapidly decrease leukocyte accumulation in the brain.
    Clemmer L; Martins YC; Zanini GM; Frangos JA; Carvalho LJ
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1383-90. PubMed ID: 21220531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malaria.
    Wilson NO; Solomon W; Anderson L; Patrickson J; Pitts S; Bond V; Liu M; Stiles JK
    PLoS One; 2013; 8(4):e60898. PubMed ID: 23630573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria.
    Yalcin O; Oronsky B; Carvalho LJ; Kuypers FA; Scicinski J; Cabrales P
    Malar J; 2015 May; 14():218. PubMed ID: 26017006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin-1 Treatment Induces an Experimental Cerebral Malaria-Like Syndrome in C57BL/6 Mice Infected with Plasmodium berghei NK65.
    Martins YC; Freeman BD; Akide Ndunge OB; Weiss LM; Tanowitz HB; Desruisseaux MS
    Am J Pathol; 2016 Nov; 186(11):2957-2969. PubMed ID: 27640146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuregulin-1 attenuates mortality associated with experimental cerebral malaria.
    Solomon W; Wilson NO; Anderson L; Pitts S; Patrickson J; Liu M; Ford BD; Stiles JK
    J Neuroinflammation; 2014 Jan; 11():9. PubMed ID: 24433482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cysteamine broadly improves the anti-plasmodial activity of artemisinins against murine blood stage and cerebral malaria.
    Moradin N; Torre S; Gauthier S; Tam M; Hawari J; Vandercruyssen K; De Spiegeleer B; Fortin A; Stevenson MM; Gros P
    Malar J; 2016 May; 15(1):260. PubMed ID: 27150250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slow and continuous delivery of a low dose of nimodipine improves survival and electrocardiogram parameters in rescue therapy of mice with experimental cerebral malaria.
    Martins YC; Clemmer L; Orjuela-Sánchez P; Zanini GM; Ong PK; Frangos JA; Carvalho LJ
    Malar J; 2013 Apr; 12():138. PubMed ID: 23617605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of artemether administered alone or in combination with praziquantel to mice infected with Plasmodium berghei or Schistosoma mansoni or both.
    Shu-Hua X; Utzinger J; Chollet J; Tanner M
    Int J Parasitol; 2006 Jul; 36(8):957-64. PubMed ID: 16750833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral artesunate prevents Plasmodium berghei Anka infection in mice.
    Gumede B; Folb P; Ryffel B
    Parasitol Int; 2003 Mar; 52(1):53-9. PubMed ID: 12543147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artesunate and erythropoietin synergistically improve the outcome of experimental cerebral malaria.
    Du Y; Chen G; Zhang X; Yu C; Cao Y; Cui L
    Int Immunopharmacol; 2017 Jul; 48():219-230. PubMed ID: 28531845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanostructured lipid carriers of artemether-lumefantrine combination for intravenous therapy of cerebral malaria.
    Prabhu P; Suryavanshi S; Pathak S; Patra A; Sharma S; Patravale V
    Int J Pharm; 2016 Nov; 513(1-2):504-517. PubMed ID: 27596113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of murine cerebral malaria by artemisone in combination with conventional antimalarial drugs: antiplasmodial effects and immune responses.
    Guiguemde WA; Hunt NH; Guo J; Marciano A; Haynes RK; Clark J; Guy RK; Golenser J
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4745-54. PubMed ID: 24913162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine cerebral malaria is associated with a vasospasm-like microcirculatory dysfunction, and survival upon rescue treatment is markedly increased by nimodipine.
    Cabrales P; Zanini GM; Meays D; Frangos JA; Carvalho LJ
    Am J Pathol; 2010 Mar; 176(3):1306-15. PubMed ID: 20110412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of endothelin-1 with a novel series of 1,3,6-trisubstituted-2-carboxy-quinol-4-ones controls infection-associated preterm birth.
    Olgun NS; Patel HJ; Stephani R; Lengyel I; Reznik SE
    Am J Pathol; 2010 Oct; 177(4):1929-35. PubMed ID: 20802183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of reactive oxygen and nitrogen intermediates in Plasmodium berghei infected mice after rescue therapy with chloroquine or artemether.
    Prada J; Müller S; Bienzle U; Kremsner PG
    J Antimicrob Chemother; 1996 Jul; 38(1):95-102. PubMed ID: 8858461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety evaluation of a novel trioxaquine in the management of cerebral malaria in a mouse model.
    Odhiambo OC; Wamakima HN; Magoma GN; Kirira PG; Malala BJ; Kimani FT; Muregi FW
    Malar J; 2017 Jul; 16(1):268. PubMed ID: 28673299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NO-Donor Dihydroartemisinin Derivatives as Multitarget Agents for the Treatment of Cerebral Malaria.
    Bertinaria M; Orjuela-Sanchez P; Marini E; Guglielmo S; Hofer A; Martins YC; Zanini GM; Frangos JA; Gasco A; Fruttero R; Carvalho LJ
    J Med Chem; 2015 Oct; 58(19):7895-9. PubMed ID: 26367273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Therapy Using a Combination of Nanotized Antimalarials and Immunomodulatory Molecules Reduces Inflammation and Prevents Parasite Induced Pathology in the Brain and Spleen of
    Mukherjee S; Ray G; Saha B; Kar SK
    Front Immunol; 2021; 12():819469. PubMed ID: 35095923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.